CULT Food Science Subsidiary Further Foods Announces Imminent FDA Trial Design for Cultivated Meat in Pet Food

TORONTO, - CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN00), a disruptive food technology platform pioneering the commercialization of lab grown meat and cellular agriculture to reshape the global food industry, is excited to announce its subsidiary, Further Foods Inc., expects to complete the design of the feeding trials necessary for regulatory approval of dog food products containing cell-cultivated chicken later this month. Cell-cultivated chicken is a new ingredient without prior approval for animal consumption and Further Foods is, in partnership with Dr. Sarah Dodd, designing a target animal safety (TAS) study to establish the inclusion of cell-cultivated chicken in future Noochies! formulations is safe and effective.

Key Takeaways

• The Company expects to submit the feeding trial design protocol to the FDA later this month and the FDA endeavors to provide a response within 45 days of submission.
• Further Foods intends to begin the feeding trials in Q4 of this year once the FDA is satisfied with the design of the protocol.
• As far as the Company is aware, Further Foods is the only company in dialogue with the FDA about feeding trials for a cultivated chicken dog treat.
• The Company is collaborating closely with leading vet nutritionist, Dr. Sarah Dodd, on the feeding trial design to ensure it achieves all FDA requirements.